Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProAmatine in Neurogenic Orthostatic Hypotension
NCT00046163Phase 4Terminated
- Sponsor
- Takeda
- Start
- Sep 2002
- Primary completion
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of midodrine in Neurogenic Orthostatic Hypotension (nOH) (4 arms), sponsored by Takeda. Primary endpoint: Average Standing Time. Started Sep 2002; status: terminated.
02
Drugs
midodrine
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT00046163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046163.